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Schiff	 base	 ligands	 are	 often	 referred	 to	 as	 “privileged	 ligands”	
because	 they	 can	 be	 obtained	 by	 simple	 self-condensation	 of	 a	
chosen	 aldehyde	 or	 ketone	 and	 primary	 amine	 precursor.	 These	
ligands	also	 show	good	efficiency	 in	binding	with	various	metals	 (d-
block	 metals,	 f-block	 metals,	 etc.).1	 Among	 the	 many	 interesting	
properties	 of	 lanthanide	 Schiff	 base	 complexes	 are	 their	
photoluminescence	properties	 (both	 in	 the	visible	and	near-infrared	
region	 NIR),	 catalytic	 activity,	 as	 well	 as	 ability	 to	 cleave	 RNA/DNA	
oligonucleotides.2-3
Introduction
Three	 unique	 crystal	 structures	 of	 La3+	 and	 Pr3+	 complexes,	with	 the	
La3+	 complex	 prepared	 in	 two	 diﬀerent	 synthePc	 approaches,	 are	
reported,	 namely	 a	 dimeric	 [La(H2L)(NO3)3]2	 complex,	 an	 asymmetric	
two-centered	 [La2(H2L)2(NO3)6]	 complex	 and	 a	 discrete	mononuclear	
[Pr(H2L)(NO3)2(H2O)2]	 complex.	 For	 Nd3+	 and	 Sm3+,	 an	 isotypic	
mononuclear	 [Nd(H2L)(NO3)3]	 and	 1D	 polymeric	 [Sm(H2L)
(NO3)3(MeOH)]n	 structure	was	 obtained,	 respecPvely.	 The	 lanthanide	
complexes	 proved	 their	 capability	 to	 cleave	 a	 20-mer	 RNA	
oligonucleoPde	 5’-AGC-GAU-AAG-AUU-CAU-AUA-UC-3’	 and	 a	 12-mer	
5’-GCA-CCC-UGU-CAG-3’	 in	 a	 non-sequence	 speciﬁc	 manner,	
demonstraPng	 an	 interesPng	 potenPal	 as	 valuable	 inorganic	
alternaPves	for	the	use	of	enzymes	or	ribozymes	for	RNA	cleavage.	
Conclusion
We	 invesPgated	 a	 series	 of	 lanthanide	 Schiﬀ	 base	 salen-type	
complexes	prepared	using	a	bis-(3-methoxysalicilidene)ethylene-1,2-
diamine	ligand	(Ln	=		La3+	-	Lu3+).	The	ability	to	cleave		a	20-mer	RNA	
oligonucleoPde:	 5’-AGC-GAU-AAG-AUU-CAU-AUA-UC-3’	 was	
invesPgated.	 Several	 of	 the	 complexes	 were	 also	 tested	 for	 the	
cleavage	 of	 12-mer	 RNA	 oligonucleoPde	 with	 a	 sequence:	 5’-GCA-
CCC-UGU-CAG-3’.	 A	 detailed	 luminescence	 study	 was	 addiPonally	
carried	out	and	revealed	that	the	Nd3+,	Er3+,	and	Yb3+	complexes	show	
strong	emission	in	the	near-infrared	region.
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Fig.	3:	NIR	Emission	spectra	of	the	(left	to	right)	Nd(H2L)(NO3)3,	Yb(H2L)(NO3)3	and	
Er(H2L)(NO3)3	complexes	(excited	at	380.0	nm).
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Fig.	1:	Cleavage	of	
the	20-mer	RNA	
oligonucleotide	by	
the	Pr3+	complex.	
Chromatogram	
overlay	of	the	
blank	RNA	
oligonucleotide	
sample	and	its	
incubation	at	24	h	
and	48	h	with	the	
complex	is	
presented.
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Crystal	structures
[La(H2L)(NO3)3] [Pr(H2L)(NO3)2(H2O)2]	
[La2(H2L)2(NO3)6][Sm(H2L)(NO3)3(MeOH)]	
Synthesis:	(A)	two-step	and	(B)	one-pot
Fig.	2:	Cleavage	of	
the	12-mer	RNA	
oligonucleotide	by	
the	Nd3+,	Sm3+	and	
Ho3+	complexes.	A	
chromatogram	
overlay	of	the	blank	
RNA	oligonucleotide	
sample	and	its	
incubation	at	24	h	
with	the	complex	is	
presented.
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